Juanoltus Expectorante

Dry extract of Hederae folium (Der 4‑8:1), the active ingredient in Juanoltus Expectorante, is a herbal expectorant presented as an oral preparation for oral use. It helps relieve productive cough and supports mucus clearance in adults and children with respiratory tract infections.

GNH USA supplies Juanoltus Expectorante as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Juanoltus Expectorante, a herbal expectorant, is used to manage conditions involving excessive or thickened bronchial mucus.

Cough with mucus: facilitates expectoration and reduces mucus viscosity. Bronchitis: helps clear bronchial secretions and eases productive cough. Upper respiratory tract infections: supports mucus clearance and alleviates chest congestion.

Adverse reactions reported with Juanoltus Expectorante are generally mild and reversible.

Common Side Effects: - Nausea - Mild abdominal discomfort - Altered taste sensation - Dizziness - Headache - Transient diarrhoea

Serious or Rare Side Effects: - Allergic reactions such as rash or angioedema - Bronchospasm in susceptible individuals - Hepatic enzyme elevation - Severe gastrointestinal bleeding (rare) - Anaphylactic shock (extremely rare)

Before using Juanoltus Expectorante, consider the following safety measures.

Pregnancy: safety not established; use only if clearly needed. Breastfeeding: insufficient data; weigh potential risks and benefits. Children: dosage should be determined by a qualified healthcare professional. Drug interactions: review concomitant mucolytic or expectorant therapy. Underlying respiratory disease: exercise caution in patients with severe asthma or COPD. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Juanoltus Expectorante may interact with other medicines; monitor for additive effects.

Major Interactions (Avoid): - Co‑administration with other mucolytic agents may increase gastrointestinal irritation. - Use with anticholinergic cough suppressants may reduce the expected expectorant effect. - Concurrent strong bronchodilators may cause excessive bronchial secretion leading to cough aggravation.

Moderate Interactions (Monitor Closely): - Combination with antihistamines may enhance sedation. - Concurrent use with warfarin could theoretically affect bleeding risk. - Use with other herbal products containing saponins may augment mucolytic activity.